In Today’s Masters in Trading: Live Last week, I went all-in on one sector that’s poised to break out in 2026 – biotech. I showed you my top three stocks to watch – and I even recommended one pick that I’m calling the sector’s best-kept secret heading into 2026. Today, we’re digging back into biotech’s next wave right as the entire sector hits a massive inflection point. Regular viewers know that biotech stocks are being thrust back into the spotlight as a whole wave of innovations in AI spark major overhauls in everything from drug discovery to diagnostic imaging. 2025 was the year this trend in biotech finally hit most traders’ radar – and the institutional money has been sending this sector into overdrive ever since. AI is just one catalyst breaking biotech wide open. The next big catalyst to watch? It all comes down to one calendar the entire biotech industry runs on like clockwork… The Prescription Drug User Fee Act (PDUFA) Calendar tracks when the Food and Drug Administration makes decisions on whether to approve the use of new drugs. Every time a PDUFA date hits, a biotech stock has the chance to soar or tank based on whether the FDA approves their drug. 2026 reveals a packed calendar of potential new approvals covering everything from skin cancer treatments to digestive disease medications. And you better believe many of these players are leveraging AI to speed up the drug discovery process and get products to market faster. We’re right on the ground floor of this massive surge in biotech stocks. And right now, the best thing we can do is keep an eye on the best players just as biotech stocks take off. In today’s episode of Masters in Trading LIVE at 11 AM EST, I’m diving deeper into my top four biotech names and showing you exactly what key catalysts and events I’m eyeing as we start off the new year. The goal here is to identify where odds are improving in the sector – not chase excitement. These names are rooted in the fundamentals we look at every day here in Masters in Trading LIVE. So make sure you tune in today to get the full story. P.S. Are you interested in taking the next step toward options mastery? The Masters in Trading Options Challenge is right here to help you in your journey. The Challenge is where we take everything you’ve learned in my daily LIVEs — fixed risk, thesis-driven exits, laddered entries, defined-duration trades, and emotional discipline — and put it into practice in a structured, step-by-step environment. For two weeks, we walk through the foundations of real options trading the way I learned them on the trading floor. You’ll learn exactly how I think, exactly how I build trades, and exactly how I manage both the winners and the losers. Just click here to check out what the Masters in Trading Options Challenge has in store for you. 
 | Got a Question? | Be sure to join me live on YouTube and ask me anything. It’s a great way to connect directly with our trading community and make sure you’re getting the insights you need to help build a deeper understanding of the markets. Remember, the creative trader wins, | 
0 Response to "LIVE: Biotech Isn’t a Coin Flip Anymore — Here Are My Top 4 Stocks to Watch"
Post a Comment